Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus
نویسندگان
چکیده
منابع مشابه
Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
Current guidelines for treatment of type 2 diabetes mellitus (T2DM) indicate a patient-centered approach that should go beyond glycemic control. Of the many antihyperglycemic agents available for treatment of T2DM, sodium-glucose cotransporter 2 (SGLT2) inhibitors offer the advantages of reduced glycated hemoglobin (A1C), body weight (BW), and systolic blood pressure (SBP) and are associated wi...
متن کاملMechanisms of Heart Failure in Type 2 Diabetes Mellitus.
cardiovascular diseases. Over the last decade, we have significantly contributed to the development of important concepts in the field of insulin signal transduction and the molecular basis of regulation of gene expression and energy metabolism. Genetic studies in worm C. elegans indicated that the insulin/IGF-1 signaling pathway via PI-3kinase→protein kinase B/Akt→Forkhead transcription factor...
متن کاملDiabetes Mellitus and Heart Failure.
Epidemiologic and clinical data from the last 2 decades have shown that the prevalence of heart failure in diabetes is very high, and the prognosis for patients with heart failure is worse in those with diabetes than in those without diabetes. Experimental data suggest that various mechanisms contribute to the impairment in systolic and diastolic function in patients with diabetes, and there is...
متن کاملPrevalence of Onychomycosis in Type 2 Diabetes Mellitus
Abstract Background and Objective: Onychomycosis is a fungal nail infection causing ulcers, diabetic foot and enhance nail infection. This study was designed to evaluate the prevalence of onychomycosis in type II diabetes. Material and methods: This descriptive-analytic study was conducted on 300 diabetic patients selected randomly among those referred to Panje Azar endocrinology clinic. ...
متن کاملEfficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
AIMS Patients with type 2 diabetes mellitus (T2DM) have increased risk of adverse events (AEs; e.g. dehydration, hypoglycaemia) in hot weather. This analysis assessed the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, in patients with T2DM who live in hot climates. METHODS This post hoc analysis evaluated patients with T2DM using pooled data from fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2018
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.118.034222